Published in Avian Dis on September 12, 1985
A murine model for assessment of living attenuated influenza A vaccines. Aust J Exp Biol Med Sci (1980) 1.62
Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun (1984) 1.52
Biophysical and biochemical characterization of hepatitis A virus. Intervirology (1982) 1.49
Live attenuated vaccines against influenza; an historical review. Vaccine (2001) 1.23
A re-examination of the molecular weight of poliovirus RNA. Biochem Biophys Res Commun (1970) 1.18
Quantitation of antibody to non-hemagglutinating viruses by single radial hemolysis: serological test for human coronaviruses. J Clin Microbiol (1977) 1.17
Evidence that the genome of hepatitis A virus consists of single-stranded RNA. J Virol (1981) 1.14
The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain OF CD36. J Biol Chem (2000) 1.14
Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant. Infect Immun (1982) 1.05
Further characterization of the genetic map of poliovirus temperature-sensitive mutants. In: strategy of the viral genome. Ciba Found Symp (1971) 1.00
Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of human colon cancer cells. Virology (1997) 0.93
The RNA of human coronavirus OC-43. Virology (1977) 0.92
The sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses. Immunology (1984) 0.90
Homotypic and heterotypic immunity of influenza A viruses induced by recombinants of the cold-adapted master strain A/Ann Arbor/6/60-ca. Arch Virol (1987) 0.88
Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain. Vaccine (2002) 0.88
The nucleic acid of infectious bronchitis virus. Arch Gesamte Virusforsch (1973) 0.88
Presence of genomic polyadenylate and absence of detectable virion transcriptase in human coronavirus OC-43. J Gen Virol (1978) 0.87
The role of cell culture vaccines in the control of the next influenza pandemic. Expert Opin Biol Ther (2004) 0.87
CD36 forms covalently associated dimers and multimers in platelets and transfected COS-7 cells. Biochem Biophys Res Commun (1997) 0.85
A clearance test in mice using non-adapted viruses to determine the immunogenicity of influenza strains. Arch Virol (1981) 0.84
A common epitope on platelet integrin alpha IIb beta 3 (glycoprotein IIbIIIa; CD41b/CD61) and alpha M beta 2 (Mac-1; CDIIb/CD18) detected by a monoclonal antibody. J Immunol (1996) 0.84
Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice. J Med Virol (2001) 0.83
Nucleic acid of infectious laryngotracheitis virus. Nature (1965) 0.82
Immunization against influenza by the ocular route. Vaccine (1985) 0.82
CD36 is spatially associated with glycoprotein IIb-IIIa (alpha IIb beta 3) on the surface of resting platelets. Biochem Biophys Res Commun (1996) 0.82
Evaluation of chicken kidney and chicken embryo kidney cultures for the large-scale growth of attenuated influenza virus master strain A/Ann/Arbor/6/60-ca. Vaccine (1985) 0.82
Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population. Vaccine (1984) 0.81
Subgrouping of respiratory syncytial virus strains from Australia and Papua New Guinea by biological and antigenic characteristics. Arch Virol (1994) 0.80
Respiratory syncytial virus: a review of the virus, its epidemiology, immune response and laboratory diagnosis. Aust Paediatr J (1986) 0.80
The role of reverse genetics in the development of vaccines against respiratory viruses. Expert Opin Biol Ther (2005) 0.80
Interference between cold-adapted (ca) influenza A and B vaccine reassortants or between ca reassortants and wild-type strains in eggs and mice. Vaccine (1994) 0.79
A model for determining immunogenic relationships between avian infectious bronchitis viruses. Arch Virol (1990) 0.79
A simple procedure for the analysis of the structural proteins of influenza and parainfluenza viruses involving adsorption to erythrocytes. J Virol Methods (1984) 0.78
Avian encephalomyelitis: a review. Avian Pathol (1994) 0.78
Field evaluations of safety and efficacy of an Australian Marek's disease vaccine. Aust Vet J (2003) 0.78
Western blot analysis of antibody responses to influenza virion proteins. Immunol Cell Biol (1992) 0.78
Some characteristics of a recent virulent isolate of Marek's disease virus. Aust Vet J (1994) 0.77
The growth of attenuated influenza vaccine donor strains in continuous cell lines. J Virol Methods (2005) 0.77
Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses. Vaccine (1997) 0.76
An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets. J Virol Methods (2003) 0.76
Efficacy of Australian vaccines against recent isolates of avian infectious bronchitis viruses. Aust Vet J (1991) 0.76
Membrane filtration enzyme immunoassay, a novel, rapid method for measurement of virus-specific immunoglobulins G and M and detection of viral antigens. J Clin Microbiol (1987) 0.75
A device for the nondestructive decontamination of large volumes of infected egg waste. Appl Environ Microbiol (1985) 0.75
Antibody responses to avian encephalomyelitis virus vaccines when administered by different routes. Aust Vet J (1992) 0.75
A comparative evaluation of chicken embryo tracheal organ cultures for the assay of avian infectious bronchitis virus. J Biol Stand (1978) 0.75
The development and evaluation of a cell culture vaccine against infectious laryngotracheitis virus. J Biol Stand (1979) 0.75
Prospects of a living attenuated vaccine against influenza. Aust J Exp Biol Med Sci (1980) 0.75
Degradation of myxovirus virion RNA by periodate. Intervirology (1975) 0.75
The RNA and proteins of human coronaviruses. Adv Exp Med Biol (1981) 0.75
Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). Vaccine (1997) 0.75
Age-related responses to influenza vaccination in the Newcastle region during 1983 and 1984. Med J Aust (1987) 0.75
Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus. Aust Vet J (2002) 0.75
Immunization against influenza by the ocular route. Brief report. Arch Virol (1983) 0.75
An improved membrane-filtration enzyme immunoassay for the rapid serological diagnosis of viral infections. J Virol Methods (1988) 0.75
A study of the advantages and limitations of immunoblotting procedures for the detection of antibodies against influenza virus. Electrophoresis (1993) 0.75
The development and evaluation of two tissue culture-grown Marek's disease challenge viruses. Avian Pathol (1998) 0.75
Purification of adenovirus 4 type-specific hemagglutinins for use in diagnostic counterelectrophoresis tests. J Med Virol (1979) 0.75
Pathogenesis of avian encephalomyelitis viruses. J Gen Virol (1991) 0.75
Attempts to extend the genetic map of poliovirus temperature-sensitive mutants. J Gen Virol (1975) 0.75
An enzyme-linked immunosorbent assay for the detection of avian encephalomyelitis virus antigens. Avian Dis (1988) 0.75
Adaptation of Marek's disease virus to the Vero continuous cell line. Vet Microbiol (2001) 0.75
Interferon-new wonder drug or old laboratory curiosity? Med J Aust (1981) 0.75
Development and application of an ELISA technique for the detection of antibody to avian encephalomyelitis viruses. Res Vet Sci (1989) 0.75
Diagnosis of a field outbreak of avian encephalomyelitis by enzyme-linked immunosorbent assay. Aust Vet J (1989) 0.75
Development and application of an improved infectivity assay for the standardization of avian encephalomyelitis vaccines. Vaccine (1990) 0.75
Further evidence that the nucleic acid of avian encephalomyelitis virus consists of RNA. Avian Dis (1993) 0.75
The development of an improved experimental yellow fever vaccine. J Biol Stand (1980) 0.75
Isolation of serotype 1 Marek's disease viruses from vaccinated Australian flocks. Vet Microbiol (1995) 0.75
The antigenicity of the chicken anaemia virus protein VP3 (Apoptin). Avian Pathol (2001) 0.75